Experience with t-PA treatment in a large south American City

Advance preferences regarding thrombolysis in patients at risk for stroke: a cross-sectional study

BACKGROUND

It is difficult to obtain informed consent for thrombolysis in stroke patients given the emergency setting, the need for a speedy decision and the effects of neurological deficits.

AIM

To determine the advance preferences for thrombolysis of patients at risk for stroke following discussion of the potential risks and benefits.

DESIGN

Cross-sectional survey.

METHODS

Data on benefits and risks of thrombolysis within 3 h and between 3 and 4.5 h after stroke were presented orally, in writing and pictorially to patients attending geriatric and stroke services in a teaching hospital with specified stroke risk factors and preferences for thrombolysis were recorded.

RESULTS

Of the 121 participants, 108 (89.3%; 95% confidence interval [CI] 82.4-93.7) would opt for thrombolysis within the 3-h period and 100 (82.6%; 95% CI 74.9-88.4) within the 3- to 4.5-h period after acute stroke (P = 0.04, McNemar's test for correlated proportions). Previous stroke or transient ischaemic attack was more common among those who agreed to thrombolysis (54.1% vs. 30.4%, P = 0.04) and those who opted for thrombolysis were significantly more likely to agree to have their preferences recorded and used in the event of a stroke than those who refused thrombolysis (88.8% vs. 30.4%, P = 0.002).

CONCLUSION

Advance discussion of the potential risks and benefits of thrombolysis in at-risk patients may improve decision making if thrombolysis is being considered and the patient can no longer make a decision.

Análise das barreiras à utilização de trombolíticos em casos de acidente vascular cerebral isquêmico em um hospital privado do Rio de Janeiro, Brasil

O acidente vascular cerebral isquêmico (AVCi) é uma importante causa de sequela e morte. A correta utilização do trombolítico enfrenta várias barreiras. O objetivo foi discutir as barreiras à terapia trombolítica em pacientes que chegam, com sintomas de AVCi agudo, à emergência de um hospital privado do Rio de Janeiro, Brasil. Coorte retrospectiva de pacientes entre 2009 e 2011. Foram admitidos 257 pacientes com suspeita de AVCi. Dos pacientes com diagnóstico confirmado (156), 11,5% (18) foram trombolisados. Dos 30 pacientes com diagnóstico de AVCi, dentro da janela terapêutica e com NIHSS na faixa para trombólise, 20 não foram trombolisados, 9 por barreiras administrativas (45%). Neste trabalho o percentual de trombólise foi superior ao observado nos Estados Unidos, mas barreiras impediram o tratamento de 45% dos pacientes com indicação à trombólise. Imagina-se que na rede pública brasileira a situação seja ainda mais desfavorável.

The NIH Stroke Scale is unreliable in untrained hands

BACKGROUND AND PURPOSE

The NIH (National Institutes of Health) Stroke Scale helps to define candidates for thrombolytic treatment and other important clinical decisions. We evaluated its use by last-year medical students who had no specific training in use of this scale.

METHODS

The scale (principles, utilization, methods for scoring, main pitfalls) was presented between 2 stroke lectures. Following a 30-minute study period, a case from the NIH training videotape (case 1, tape 2, total score 4) was presented, and the 13 items were scored by 42 voluntary students. The analysis focused on possible errors of potential clinical relevance.

RESULTS

Only 15 students (36%) scored all items correctly. Twenty (48%) gave results at least 2 points apart from the correct total score, and 14 students had scores > or = 6, which could lead to the inappropriate use of recombinant tissue-type plasminogen activator (rt-PA). At least 10% of the students made mistakes in most (8 of 13) items of the scale.

CONCLUSIONS

Graduating medical students are not ready to use the NIH Stroke Scale without specific training. The magnitude of the mistakes found in this study is enough to inappropriately include or exclude patients from rt-PA treatment. Training programs should be considered a sine qua non for qualification for rt-PA use in daily clinical practice.

Lack of t-PA use for acute ischemic stroke in a community hospital: high incidence of exclusion criteria

Thrombolytic therapy with t-PA for acute ischemic stroke may provide benefit in long-term outcome. This retrospective study was undertaken to evaluate appropriateness of the National Institute of Neurological Disorders and Stroke (NINDS) protocol in the emergency department (ED). All patients with appropriate International Classification of Diseases, 9th revision (ICD-9) codes indicating stroke who presented to our 387-bed trauma-I community hospital during 1997 were included in the study. Of the nearly 35,000 patients screened, 201 patients satisfied our inclusion criteria. Mean age was 73.5 +/- 13.3 years. Men were evaluated and transported to computed tomography more rapidly and older patients more slowly. Nonwhites were more likely to arrive via emergency medical services (EMS). Average time from EMS arrival at scene to ED arrival was 22.7 minutes, and from ED arrival to triage was 8.4 minutes. The most common reason for exclusion from t-PA administration was delayed presentation (n = 188); this is the most serious barrier to use of t-PA for acute ischemic stroke. Extensive public education may combat this.